Current approach to asthma diagnosis and treatment in children

Česká verzia

Authors: J. Chládková
Authors place of work: Dětská klinika Lékařské fakulty v Hradci Králové, Univerzity Karlovy v Praze a Fakultní nemocnice, Hradec Králové
Published in the journal: Čes-slov Pediat 2018; 73 (3): 124-129.
Category:

Summary

Asthma is the most common chronic disease in children, characterized by chronic airway inflammation. The diagnosis of asthma should be based on the history of characteristic symptom patterns and evidence of variable airflow limitation. Pharmacotherapy with regular low dose inhaled corticosteroids is higly effective in reducing asthma symptoms and reducing the risk of asthma-related exacerbations, hospitalization and death.

Key words:
asthma, children, variable airflow limitations, low dose inhaled corticosteroids

Zdroje

1. Pohunek P. Průduškové astma v dětském věku. Funkční vyšetření plic. In: Petrů V, a kol. Dětská alergologie. Praha: Mladá fronta, 2012: 1–239.

2. Alving K, Malinovski A. Basic aspects of exhaled nitric oxide. In: Horvath I, de Jongste JC. Exhaled Biomarkers. European Respiratory Society Momograph 2010; 49: 1–31.

3. Petrů V. Klinická diagnostika. Alergenové testy. In: Petrů V, a kol. Dětská alergologie. Praha: Mladá fronta, 2012: 77.

4. 2017 GINA Report. Global Strategy for Asthma Management and Prevention Global Initiative for Asthma. NHLBI/WHO. NIH Publication No.02-3659.

5. Rodrigo GJ. Daily versus intermittent inhailed coticosteroid treatment for mild president asthma. Curr Opin Allergy Clin Immunol 2014; 3: 186–191.

6. Zhang L, Priettsch SOM, Ducharme FM. Inhaled corticosteroids in children with persistent asthma. Effects on growth. Cochrane Database Syst Rev 2014; 7: CD 009471.

7. The Childhood Asthma Management Program (CAMP) Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054–1063.

8. Fuhlbrigge A, Kelly WHEN. Inhaled corticosteroid in children: effects on bone mineral density and growth. J Paediatr Child Health 2016; 52: 964–966.

9. Haarman MG, van Hunsel F, De Vries TW. Adverse reactions of montelukast in children and adults. Pharma Res Per 2017; 5: 1–8.